Codexis
CDXS | NASDAQ
$1.04
-$0.12 (-10.34%)
At close: Nov 16, 2026, 3:59 PM ET
$1.01
-$0.03 (-2.88%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-10.34%
(1D)No price chart data available for 1D timeframe.
Rating
53.8
+2.0 ptsFundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #204/1021 (Top 20%)
Key Statistics
Market Data
Market Cap $114.53M
1D Range
1.04 1.16
52W Range
0.96 2.85
Valuation (TTM)
PE -5.20
PB 2.24
EV/EBITDA -11.32
Valuation (NTM)
Forward PE N/A
Forward PEG 0.14
Price Target $5.00
Cash Flow
FCF Yield -10.6%
SBC Adj. FCF Yield -16.5%
SBC Impact -55.7%
Margins
Gross Margin 83.9%
Operating Margin -14.4%
FCF Margin -13.7%
Growth (CAGR)
Revenue 3Y | 5Y 6.1% |
-2.7%
Dil EPS 3Y | 5Y 54.9% |
14.3%
FCF 3Y | 5Y 42.5% |
-9.2%
Returns
ROA -13.3%
ROE -43.2%
ROIC -10.2%
Financial Health
Net Cash
$31.38M
Current Ratio 2.81
Interest Coverage -9.50
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalys...
Sector Healthcare
Industry Biotechnology
Employees 146
IPO Date Apr 22, 2010
Website www.codexis.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.08
Beat +16.41%
YoY:
+63.64% REV
$19.26M
Beat +2.89%
YoY:
+123.95%Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+380.77%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CDXS